Te Pāti Māori Call On Te Whatu Ora To Immediately Publish Gender Affirming Care Guidelines
Press Release – Te Pati Maori
Guidelines for safe medical practice should be left to experts and practitioners, not politicians, said Te Pti Mori co-leader Debbie Ngarewa-Packer. Te Pti Mori condemns any political manoeuvring that threatens the safety and wellbeing of marginalised …
Te Pāti Māori join health professionals, medical bodies, and community organisations across Aotearoa in calling on Te Whatu Ora to immediately release the updated Guidelines for Gender Affirming Healthcare.
The guidelines were developed by medical professionals with expertise in this form of care and approved by Te Whatu Ora's National Clinical Governance Group. They were due for release in March 2025 but have been indefinitely delayed due to political interference from the new Health Minister.
'Guidelines for safe medical practice should be left to experts and practitioners, not politicians' said Te Pāti Māori co-leader Debbie Ngarewa-Packer.
'The delay of these guidelines is clear political interference by a government that has continually attacked the mana and hauora of our trans and non-binary whānau for votes'
Te Pāti Māori condemns any political manoeuvring that threatens the safety and wellbeing of marginalised communities. 'It is extremely unsafe for politicians to interfere in decisions relating to life affirming care for children and adults'.
'These guidelines are essential for safe, evidence-based care. They reflect the lived realities and clinical needs of our trans and non-binary people. Holding them back only furthers harm.
'This is not just a healthcare issue – it's a human rights issue' said Ngarewa-Packer.
Te Pāti Māori echoes the call of the Professional Association for Transgender Health Aotearoa in demanding the government allow Te Whatu Ora to publish the guidelines without further delay.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Otago Daily Times
5 hours ago
- Otago Daily Times
Left bloc could turf coalition out of power: poll
By Russell Palmer of RNZ After the Budget and pay equity changes the left bloc would have the support to turf the coalition out of power, the latest RNZ-Reid Research poll shows. The preferred prime minister and leadership ratings are also bad news for the government, with the exception of Winston Peters who has seen his highest result since 2017 - and ratings of the government's general performance have also continued to slide. With Labour, the Greens and Te Pāti Māori all gaining compared to the previous poll taken in March, they would have a majority with 63 seats between them, compared to the coalition's 57 - again, New Zealand First was the only coalition party to see a boost. The poll was taken in the seven days following the release of the Budget and in the wake of the $12.8 billion pay equity changes - which RNZ's polling also shows attracting more opposition than support. National continued a downward trend from the March survey, dropping 2.2 percentage points to 30.7 percent of the party vote - and overtaken by Labour, which gained 0.9 percentage points to 33.2 percent. The Greens' 1.6 percent increase brings them back to their election-night result of 11.6 percent, while Te Pāti Māori's 0.5 percentage point boost lifts them clear of the 5 percent threshold and - presuming they held all Māori seats - nets them a list MP. ACT dropped 2.8 points to 6.6 percent - the largest shift in party polling - while New Zealand First gained 1.9 points to 9.1 percent, upending the trend facing their coalition partners. Undecided or non-voters made up 6.5 percent of those polled - up from 6.1 in the previous poll. For parties outside Parliament, TOP (The Opportunities Party) gained 0.4 points to 2.2 percent, New Conservatives fell 0.3 points to 0.8, and all others combined were at 0.3 points, a 0.1 point increase on the last survey. More New Zealanders polled say the country is going in the wrong direction (46.6 percent) than in the right direction (37.8 percent), giving a net negative result of -8.8, a substantial decrease on March's 2.9 result. Little surprise then to see National leader Christopher Luxon's net favourability ratings drop further into the negative, from -3.9 percent in March to -9.8 percent, with significantly more respondents (45.5 percent) saying he performed poorly or very poorly, than said he performed well or very well (35.7 percent). That compared to Labour's Chris Hipkins on net 5.1 percent rating (34 percent negative, 39.1 percent positive) - though Hipkins also saw a steeper fall of 7.1 percentage points. The survey shows New Zealanders' preferred prime minister as Hipkins (23.2 percent, up 2.3), taking the lead over Luxon (18.8 percent, down 3.1). NZ First leader Winston Peters at 8.9 percent (up 1 point) recorded his highest result since 2017. Chlöe Swarbrick in fourth was at 6.9 percent (up 0.8) - a personal best and just ahead of ACT's David Seymour on 6.4 percent (down 0.4). The next highest ratings were former PM Jacinda Ardern (3.7 percent, up 0.1), Te Pāti Māori MP Hana-Rawhiti Maipi-Clarke (1.7 percent, up 0.5), Finance Minister Nicola Willis (1.1, up 0.3) and Education/Immigration Minister Erica Stanford making her first appearance at 1 percent. 'I don't recognise the numbers' - Coalition plays down poll Luxon simply rejected the poll results. "Look, I mean, I don't recognise the numbers. There's lots of different polls and frankly I'm just not going to comment or focus on the polls. Frankly what we're focused on is we were elected in '23 and people get to decide again in 2026. "We've done a good job, and that's why we've got to focus on the economy, law and order, and health and education." He said New Zealanders had "responded really positively" to the government's Budget, and saw the economy turning a corner. "There's a sense of optimism that, you know, we actually have had to manage some very difficult things economically to get our books back in order. But we're doing that job, and it's all about growth, growth, growth." Seymour said the numbers would continue to "bounce around" but it was still a tough time for New Zealanders - and the numbers were not a reflection on the Budget. "Different voters will have different reasons for their choices ... so long as people are voting for the economy, it's going to be tough for parties that are tied closely to economic management," he said. It was possible the pay equity changes were changing some voters' minds, he said, "but I also think doing what is right is what is politically popular in the long term, and even if I'm wrong about that, good policy is worth it anyway". "The fact that ACT is close to where it was on election night 18 months into a government with 18 months to go is a good foundation. We have to prove ourselves on election night, and we've got lots of time to do that." Peters refused to comment on whether his coalition partners were suffering from the handling of the pay equity changes. The next 18 months leading up to the election would show the "critical need for stability", he said, and having ruled out working with Chris Hipkins he was "comfortable and confident in our prospects" because the Greens and Te Pāti Māori in government would be "a nightmare". The 80-year-old Peters said economies internationally were in trouble as a result of "unprecedented times for the last, say, 80 years", and the party was looking at New Zealand's fundamentals: asset values, and the need to increase wages and decrease business tax. "We're out there to ensure over the next few months that we can show enough improvement in the economy from what we're doing to make the prospects of an improved tomorrow possible." 'Nice to be popular' - Opposition Hipkins was also not counting his electoral chickens, but was happy to point out the effect of the Budget, saying New Zealanders were "disillusioned" with the government overall. "New Zealanders can increasingly see that this government is taking the country backwards," he said. "I don't think anyone expected the government to cancel pay equity as a way of balancing its books. Nicola Willis and Christopher Luxon told New Zealanders before the election that they knew their numbers, that everything all added up. It's clear that their numbers didn't add up." He said he did not pay much attention to small shifts from the minor parties or his personal ratings in the polls. "It's nice to be popular, but I'm really focused on making sure I win as many votes as possible for Labour at the next election." Swarbrick said New Zealanders wanted a sense of hope. "Things are feeling pretty bloody bleak. You know, we've got 191 New Zealanders leaving every single day, three quarters of them between the ages of 18 to 45, it's not a recipe for a flourishing country. "We had dozens and dozens of folks turn out to talk to us about our Green budget and the sense of hope that they feel that they need - the kind of building blocks that we can have for a fairer society." She said polls did not mean the writing was on the wall, but she was hearing from people that they were exhausted and fatigued - something she suggested was a deliberate strategy from the coalition. Te Pāti Māori's co-leader Rawiri Waititi said the poll numbers showed the party's policies and rhetoric around the government's actions were appealing to new supporters. "The kind of anti-Māori, anti-wāhine, anti-woman, anti-worker, anti-climate, anti-rainbow, anti-woke type agenda that this government is pushing at the moment also is not appealing to the people who are trying to find a place to put their political support and trying to support those who fiercely advocate for them." He said their internal polling showed even higher support for the party and its style of politics - but the decreased support for ACT and increase for NZ First was a zero-sum game. "You've got a hard-right type voter ... I think they think that National is a little bit weak, which I agree [with] because they're allowing ACT to kind of run the show ... they will use Te Pāti Māori as their political football to kick us in the guts the hardest to garner the support of their voters, but at the end of the day the enemy for ACT is New Zealand First, and the enemy for New Zealand First is ACT." Explore the full results with RNZ's interactive charts. This poll of 1008 people was conducted by Reid Research, using quota sampling and weighting to ensure a representative cross section by age, gender and geography. The poll was conducted through online interviews between 21-27 March 2025 and has a maximum margin of error of +/- 3.1 percent at a 95 percent confidence level. The report is available here.
Scoop
4 days ago
- Scoop
Health Professionals Concerned At Further Delays To Gender Affirming Healthcare Guidelines
Press Release – PATHA This is clear evidence of ideological interference in an operational, professional frontline medical resource that is being requested by the health sector. We reiterate our call for the Government to allow Te Whatu Ora Health New Zealand to publish these … The Professional Association for Transgender Health Aotearoa (PATHA) is deeply concerned at further delays to the publication of updated Guidelines for Gender Affirming Healthcare in Aotearoa New Zealand. PATHA has been informed by Te Whatu Ora | Health New Zealand that the updated Guidelines will not be published until the Minister of Health decides on whether to introduce regulations on the ability of medical professionals to prescribe puberty blockers as part of gender affirming healthcare. The guideline's advice on prescribing puberty blockers was updated in November 2024 to reflect the Ministry of Health's position statement on the use of these medications. This advice spans just 6 of the total 182 pages of information contained in the guidelines. The guidance is evidence-based, aligns with international best practice and guidelines, and supports a holistic approach to gender affirming medical care for young people who need it. 'Medical professionals working in this area are constantly being asked by colleagues for clinical guidance on gender-affirming healthcare,' says Dr Rona Carroll, a Specialist General Practitioner and Vice-President of PATHA. 'By not publishing the updated guidelines, the government is stopping healthcare providers from being guided by evidence-based, up-to-date New Zealand specific information. We have been given no timeframe for when to expect a decision about the puberty blocker consultation or the updated guidelines. Considering how many other areas of health these guidelines include, and that the advice on prescribing puberty blockers is in line with the Ministry's position statement, the updated guidelines should be published immediately. I think clinicians would be providing safer care if they had access to these guidelines today.' On Wednesday, 28 May, PATHA published an open letter calling on the Minister of Health, Simeon Brown and the Associate Minister for Health, Matt Doocey, to release the updated guidance. This letter was signed by over 500 medical bodies, clinicians and community organisations. Signatories include the Royal New Zealand College of General Practitioners, the New Zealand Society of Endocrinology, the College of Child and Youth Nurses, and the Paediatric Society of New Zealand. The evidence-based guidelines, which have been peer reviewed by clinicians with expertise in this care from within New Zealand and internationally, provide detailed information on a wide range of topics relevant to healthcare for transgender and non-binary people. This includes several revised chapters from the 2018 edition in line with emerging medical research. 'I'm proud of the amount of work the authors have put into these guidelines, bringing their extensive collective expertise into creating guidance that is broad and has a holistic view of transgender health,' says Jennifer Shields, PATHA President. 'These guidelines cover so much more than puberty blocker medication, and this information is important for all healthcare workers to have.' 'It is clear that there is no evidence-based justification for considering restrictions on prescribing puberty blockers to transgender young people,' Shields says. 'These medications continue to be prescribed to children for other indications, and limitations in the quality of the academic evidence are not unique to this care. Healthcare professionals are now left wondering if this government is being pulled into alarming 'culture war' trends away from best practice medical care, and into anti-transgender policies that lead to a reduction in patients' rights and freedoms, and set precedent for making clinical decisions based on political beliefs rather than what's best for patients.' 'This is clear evidence of ideological interference in an operational, professional frontline medical resource that is being requested by the health sector,' Carroll said. 'We reiterate our call for the Government to allow Te Whatu Ora Health New Zealand to publish these updated guidelines immediately.' Background information Statement on puberty blockers On 21st November 2024, the Ministry of Health published a position statement on the use of puberty blockers in gender affirming care, emphasising that puberty blockers could continue to be prescribed when needed as part of interdisciplinary teams. The Government expressed an intention to explore further restrictions on access to this care, and opened public consultation on possible restrictions. This consultation closed on 20th January 2025. A memo sent to then Minister of Health Shane Reti on 30 April 2024 was released to PATHA under the Official Information Act. In this memo, the Ministry of Health clarified that: 'There is currently no evidence that individual clinicians are prescribing [puberty blockers] outside of an interprofessional team.' This shows that concerns about individual professionals prescribing puberty blockers inappropriately are unfounded, and current prescribing practices are already in line with the Ministry's position statement. PATHA previously published a collective statement opposing the restrictions the Government is considering on the prescription of puberty blockers to transgender young people. This statement also received broad support from medical bodies, including the New Zealand Paediatrics Society and the New Zealand Society of Endocrinology. The statement reads [in part]: 'The Ministry of Health Evidence Brief identified that any evidence of harm associated with providing puberty-blocking medication is limited and inconclusive, and withholding this care may exacerbate gender dysphoria and negatively impact mental health. Equitable and non-discriminatory access to this care should be provided and maintained throughout the country. Decisions about prescribing puberty blockers should continue to be made collaboratively between young people, their families or support people, and the health professionals involved in their care. These decisions are individualised, based on informed consent, and guided by professional training, clinical experience, and the best available evidence. Any move to restrict access to puberty blockers would be a political decision and not one based on clinical guidance from health experts in New Zealand and international best practice. Medical decisions should remain free from political interference.' Background on puberty blockers Puberty blockers are a medication called gonadotrophic releasing hormone (GnRH) agonists. They were developed in the 1980s for use in much younger children with precocious (early) puberty, and have been used in gender affirming care for over 20 years. They halt the development of secondary sexual characteristics, such as breast growth or voice deepening, and can relieve distress associated with these bodily changes for transgender young people. Puberty blockers have the benefit of allowing the young person time before making any decisions regarding starting on gender affirming hormone therapy. The effect puberty blockers have on pausing pubertal changes is reversible. Once the puberty blocker medication has been stopped, puberty will resume as it would have done without medication. All medications have known or potential risks, but evidence and experience to date does not raise significant concerns about the safety of puberty blockers. As is the case in all medical prescribing, risks, side effects and benefits of medications are discussed with patients as part of the informed consent process before prescribing. There are also risks to not prescribing medications when they are indicated. Puberty results in irreversible physical changes, which can result in lifelong distress and gender dysphoria for some transgender people. In every area of healthcare, decisions about treatment and medication prescribing take all of these aspects into account, and health professionals support patients and their families to weigh up the pros and cons for their individual situation. Gender affirming healthcare is no different. Decisions about whether to start puberty blockers are made between health professionals, young people and their whānau. These are healthcare decisions which should remain free from ideological political interference. Clinicians who initiate puberty blockers should be experienced in providing gender affirming healthcare and working within an interdisciplinary team. It is essential that access to this care and to puberty blocker medication is maintained. Topics covered by the updated Guidelines Advice on the prescription of puberty blockers is a small portion of the content covered by the updated guidelines. The updated guidance also includes detailed information on a broad number of other areas of transgender health, including whānau support, creating inclusive clinical environments, non-medical and non-surgical gender affirmation, speech and language therapy, fertility and sexual health, mental wellbeing, gender-affirming hormone therapy, and detransition, as well as specific guidance for Māori, Pasifika, and refugee and asylum seeker trans people.
Scoop
5 days ago
- Scoop
Health Professionals Concerned At Further Delays To Gender Affirming Healthcare Guidelines
The Professional Association for Transgender Health Aotearoa (PATHA) is deeply concerned at further delays to the publication of updated Guidelines for Gender Affirming Healthcare in Aotearoa New Zealand. PATHA has been informed by Te Whatu Ora | Health New Zealand that the updated Guidelines will not be published until the Minister of Health decides on whether to introduce regulations on the ability of medical professionals to prescribe puberty blockers as part of gender affirming healthcare. The guideline's advice on prescribing puberty blockers was updated in November 2024 to reflect the Ministry of Health's position statement on the use of these medications. This advice spans just 6 of the total 182 pages of information contained in the guidelines. The guidance is evidence-based, aligns with international best practice and guidelines, and supports a holistic approach to gender affirming medical care for young people who need it. 'Medical professionals working in this area are constantly being asked by colleagues for clinical guidance on gender-affirming healthcare,' says Dr Rona Carroll, a Specialist General Practitioner and Vice-President of PATHA. 'By not publishing the updated guidelines, the government is stopping healthcare providers from being guided by evidence-based, up-to-date New Zealand specific information. We have been given no timeframe for when to expect a decision about the puberty blocker consultation or the updated guidelines. Considering how many other areas of health these guidelines include, and that the advice on prescribing puberty blockers is in line with the Ministry's position statement, the updated guidelines should be published immediately. I think clinicians would be providing safer care if they had access to these guidelines today.' On Wednesday, 28 May, PATHA published an open letter calling on the Minister of Health, Simeon Brown and the Associate Minister for Health, Matt Doocey, to release the updated guidance. This letter was signed by over 500 medical bodies, clinicians and community organisations. Signatories include the Royal New Zealand College of General Practitioners, the New Zealand Society of Endocrinology, the College of Child and Youth Nurses, and the Paediatric Society of New Zealand. The evidence-based guidelines, which have been peer reviewed by clinicians with expertise in this care from within New Zealand and internationally, provide detailed information on a wide range of topics relevant to healthcare for transgender and non-binary people. This includes several revised chapters from the 2018 edition in line with emerging medical research. 'I'm proud of the amount of work the authors have put into these guidelines, bringing their extensive collective expertise into creating guidance that is broad and has a holistic view of transgender health,' says Jennifer Shields, PATHA President. 'These guidelines cover so much more than puberty blocker medication, and this information is important for all healthcare workers to have.' 'It is clear that there is no evidence-based justification for considering restrictions on prescribing puberty blockers to transgender young people,' Shields says. 'These medications continue to be prescribed to children for other indications, and limitations in the quality of the academic evidence are not unique to this care. Healthcare professionals are now left wondering if this government is being pulled into alarming 'culture war' trends away from best practice medical care, and into anti-transgender policies that lead to a reduction in patients' rights and freedoms, and set precedent for making clinical decisions based on political beliefs rather than what's best for patients.' 'This is clear evidence of ideological interference in an operational, professional frontline medical resource that is being requested by the health sector,' Carroll said. 'We reiterate our call for the Government to allow Te Whatu Ora Health New Zealand to publish these updated guidelines immediately.' Background information Statement on puberty blockers On 21st November 2024, the Ministry of Health published a position statement on the use of puberty blockers in gender affirming care, emphasising that puberty blockers could continue to be prescribed when needed as part of interdisciplinary teams. The Government expressed an intention to explore further restrictions on access to this care, and opened public consultation on possible restrictions. This consultation closed on 20th January 2025. A memo sent to then Minister of Health Shane Reti on 30 April 2024 was released to PATHA under the Official Information Act. In this memo, the Ministry of Health clarified that: 'There is currently no evidence that individual clinicians are prescribing [puberty blockers] outside of an interprofessional team.' This shows that concerns about individual professionals prescribing puberty blockers inappropriately are unfounded, and current prescribing practices are already in line with the Ministry's position statement. PATHA previously published a collective statement opposing the restrictions the Government is considering on the prescription of puberty blockers to transgender young people. This statement also received broad support from medical bodies, including the New Zealand Paediatrics Society and the New Zealand Society of Endocrinology. The statement reads [in part]: 'The Ministry of Health Evidence Brief identified that any evidence of harm associated with providing puberty-blocking medication is limited and inconclusive, and withholding this care may exacerbate gender dysphoria and negatively impact mental health. Equitable and non-discriminatory access to this care should be provided and maintained throughout the country. Decisions about prescribing puberty blockers should continue to be made collaboratively between young people, their families or support people, and the health professionals involved in their care. These decisions are individualised, based on informed consent, and guided by professional training, clinical experience, and the best available evidence. Any move to restrict access to puberty blockers would be a political decision and not one based on clinical guidance from health experts in New Zealand and international best practice. Medical decisions should remain free from political interference.' Background on puberty blockers Puberty blockers are a medication called gonadotrophic releasing hormone (GnRH) agonists. They were developed in the 1980s for use in much younger children with precocious (early) puberty, and have been used in gender affirming care for over 20 years. They halt the development of secondary sexual characteristics, such as breast growth or voice deepening, and can relieve distress associated with these bodily changes for transgender young people. Puberty blockers have the benefit of allowing the young person time before making any decisions regarding starting on gender affirming hormone therapy. The effect puberty blockers have on pausing pubertal changes is reversible. Once the puberty blocker medication has been stopped, puberty will resume as it would have done without medication. All medications have known or potential risks, but evidence and experience to date does not raise significant concerns about the safety of puberty blockers. As is the case in all medical prescribing, risks, side effects and benefits of medications are discussed with patients as part of the informed consent process before prescribing. There are also risks to not prescribing medications when they are indicated. Puberty results in irreversible physical changes, which can result in lifelong distress and gender dysphoria for some transgender people. In every area of healthcare, decisions about treatment and medication prescribing take all of these aspects into account, and health professionals support patients and their families to weigh up the pros and cons for their individual situation. Gender affirming healthcare is no different. Decisions about whether to start puberty blockers are made between health professionals, young people and their whānau. These are healthcare decisions which should remain free from ideological political interference. Clinicians who initiate puberty blockers should be experienced in providing gender affirming healthcare and working within an interdisciplinary team. It is essential that access to this care and to puberty blocker medication is maintained. Topics covered by the updated Guidelines Advice on the prescription of puberty blockers is a small portion of the content covered by the updated guidelines. The updated guidance also includes detailed information on a broad number of other areas of transgender health, including whānau support, creating inclusive clinical environments, non-medical and non-surgical gender affirmation, speech and language therapy, fertility and sexual health, mental wellbeing, gender-affirming hormone therapy, and detransition, as well as specific guidance for Māori, Pasifika, and refugee and asylum seeker trans people.
